어댑티뮨의 Tecelra, 첫 고형 종양 T세포 치료제로 FDA 승인

Category

인허가

Type

Approval

Official Announcement

https://www.adaptimmune.com/investors-and-media/news-center/press-releases/detail/271/adaptimmune-receives-u-s-fda-accelerated-approval-of

BioPharma Dive

https://www.biopharmadive.com/news/adaptimmune-tecelra-fda-approval-synovial-sarcoma-tcr-cell-therapy/723156/

BioSpace

https://www.biospace.com/fda/adaptimmunes-tecelra-becomes-first-fda-approved-engineered-cell-therapy-for-solid-tumors

Firstword

https://firstwordpharma.com/story/5881518

Fierce Group

https://www.fiercepharma.com/pharma/adaptimmune-scores-fda-nod-first-engineered-cell-therapy-solid-tumor

Release Date

2024/08/05

14 more properties

BioPharma Dive

BioSpace

Firstword

Fierce Group